House of Transplant & Cancer

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Phone

3104000645

Tax Period

2023-01-01 to 2023-12-31

House of Transplant & Cancer, founded in 2018, is a community nonprofit in the Health Care sector that reported $1.0M in total revenue in fiscal year 2023. Revenue decreased 8% compared to the prior year. Expenses of $1.3M exceeded revenue, resulting in a 25% operating deficit.

Mission

The specific purpose of this corporation is to provide health care, scientific, and public health services to people with medical illness.

Program Service Accomplishments

Program 1

Expenses: $1,153,529 Revenue: $1,043,774

Providing health care, scientific, and public health services to people with medical illness.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $76

Program Service Revenue $1,043,774

Investment Income $-18,226

Other Revenue $0

TOTAL REVENUE $1,025,624

Expense Breakdown

Grants Paid $205

Salaries & Benefits $880,812

Fundraising Expenses $0

Program Expenses $1,153,529

Other Expenses $400,658

TOTAL EXPENSES $1,281,675

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,025,624	$1,118,857	-0.1%
Expenses	$1,281,675	$1,166,785	+0.1%
Net Income	$-256,051	$-47,928	+4.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Alagappan Annamalai	CEO	25.00	Director	$0	$0	$0
Elise Diner	CEO	40.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,025,624	$1,281,675	$295,517	$-256,051
2022	$1,118,857	$1,166,785	$401,683	$-47,928